Universe Pharmaceuticals (UPC) Shares Outstanding (Diluted Average) (2020 - 2022)

Universe Pharmaceuticals' (UPC) quarterly Shares Outstanding (Diluted Average) came in at $6042.0 in Q3 2022, down 99.81% year-on-year from $3.2 million in Q3 2021, and down 99.81% quarter-over-quarter from $3.2 million in Q3 2021.

Universe Pharmaceuticals (UPC) Shares Outstanding (Diluted Average) (2020 - 2022) Analysis & Trends

Universe Pharmaceuticals has disclosed Shares Outstanding (Diluted Average) across 3 years of filings, most recently posting $6042.0 for Q3 2022.

  • Shares Outstanding (Diluted Average) for Q3 2022 came in at $6042.0, down 99.81% year-over-year; the trailing twelve-month figure through Sep 2022 was $6042.0 (down 99.81% YoY), and the FY2022 annual result was $6042.0, up 763.14% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $6042.0 for Q3 2022 at Universe Pharmaceuticals, down from $3.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $16.0 million in Q3 2020 to a low of $6042.0 in Q3 2022.
  • The 3-year median for Shares Outstanding (Diluted Average) is $3.2 million (2021), against an average of $6.4 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) plunged 80.23% in 2021 and slumped 99.81% in 2022, its largest moves.
  • Universe Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $16.0 million in 2020, then slumped by 80.23% to $3.2 million in 2021, then plunged by 99.81% to $6042.0 in 2022.
  • The last three Shares Outstanding (Diluted Average) figures came in at $6042.0 (Q3 2022), $3.2 million (Q3 2021), and $16.0 million (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Universe Pharmaceuticals - - - -

Historic Data

Download Data
DateValue
Sep 30, 2022 6,042.00
Sep 30, 2021 3.16 Mn
Sep 30, 2020 16.00 Mn